Clinical Trial Update: Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants [Phase 4]

View source ↗

Summary

Phase 4 trial findings suggest a strategy to determine the optimal duration of oral anticoagulants for deep vein thrombosis based on residual vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Snippet

Sponsor: Azienda Ospedaliera Universitaria Policlinico | Conditions: Deep Vein Thrombosis | Phase 4 | Status: COMPLETED